| Literature DB >> 29785087 |
Ransom L Baldwin1, Robert W Li1, Yankai Jia2, Cong-Jun Li1.
Abstract
The purpose of this study was to evaluate the effects of butyrate infusion on rumen epithelial transcriptome. Next-generation sequencing (NGS) and bioinformatics are used to accelerate our understanding of regulation in rumen epithelial transcriptome of cattle in the dry period induced by butyrate infusion at the level of the whole transcriptome. Butyrate, as an essential element of nutrients, is a histone deacetylase (HDAC) inhibitor that can alter histone acetylation and methylation, and plays a prominent role in regulating genomic activities influencing rumen nutrition utilization and function. Ruminal infusion of butyrate was following 0-hour sampling (baseline controls) and continued for 168 hours at a rate of 5.0 L/day of a 2.5 M solution as a continuous infusion. Following the 168-hour infusion, the infusion was stopped, and cows were maintained on the basal lactation ration for an additional 168 hours for sampling. Rumen epithelial samples were serially collected via biopsy through rumen fistulae at 0-, 24-, 72-, and 168-hour (D1, D3, D7) and 168-hour post-infusion (D14). In comparison with pre-infusion at 0 hours, a total of 3513 genes were identified to be impacted in the rumen epithelium by butyrate infusion at least once at different sampling time points at a stringent cutoff of false discovery rate (FDR) < 0.01. The maximal effect of butyrate was observed at day 7. Among these impacted genes, 117 genes were responsive consistently from day 1 to day 14, and another 42 genes were lasting through day 7. Temporal effects induced by butyrate infusion indicate that the transcriptomic alterations are very dynamic. Gene ontology (GO) enrichment analysis revealed that in the early stage of rumen butyrate infusion (on day 1 and day 3 of butyrate infusion), the transcriptomic effects in the rumen epithelium were involved with mitotic cell cycle process, cell cycle process, and regulation of cell cycle. Bioinformatic analysis of cellular functions, canonical pathways, and upstream regulator of impacted genes underlie the potential mechanisms of butyrate-induced gene expression regulation in rumen epithelium. The introduction of transcriptomic and bioinformatic technologies to study nutrigenomics in the farm animal presented a new prospect to study multiple levels of biological information to better apprehend the whole animal response to nutrition, physiological state, and their interactions. The nutrigenomics approach may eventually lead to more precise management of utilization of feed resources in a more effective approach.Entities:
Keywords: Butyrate; Dairy Cattle; epithelium; rumen; transcriptome
Year: 2018 PMID: 29785087 PMCID: PMC5954180 DOI: 10.1177/1177625018774798
Source DB: PubMed Journal: Gene Regul Syst Bio ISSN: 1177-6250
Figure 1.Volcano plots: the differentially expressed genes at different sampling time points after butyrate infusion (red dots indicate differentially expressed genes at cutoff of FDR < 0.01).
Number of genes impacted by butyrate infusion in rumen epithelium.
| Time Point | Total genes impacted | Upregulated gene | Downregulated gene |
|---|---|---|---|
| D1 | 931 | 480 | 451 |
| D3 | 629 | 235 | 394 |
| D7 | 2186 | 1434 | 752 |
| D14 | 1127 | 555 | 572 |
In comparison with pre-infusion at 0 hours, genes were identified to be impacted in the rumen epithelium by butyrate infusion at a stringent cutoff of FDR < 0.01.
Figure 2.Venn diagram of genes impacted by butyrate infusion at different sampling time points. All 4 sampling time points: (A) day 1, day 4, day 7, and day 14 compared against day 0 and (B) day 4, day 7, and day 14 compared against day 1.
Top 5 of the GO terms in biological process significantly impacted temporally by butyrate infusion.
| GO term | Description | Ratio | FDR | Bonferroni | |
|---|---|---|---|---|---|
| Day 1 | |||||
| 1903047 | Mitotic cell cycle process | 113/29 | 6.99E–13 | 5.78E–09 | 5.78E–09 |
| 22402 | Cell cycle process | 169/33 | 5.82E–11 | 2.41E–07 | 4.82E–07 |
| 51726 | Regulation of cell cycle | 163/29 | 8.78E–09 | 2.42E–05 | 7.26E–05 |
| 7059 | Chromosome segregation | 26/10 | 4.77E–07 | 9.86E–04 | 3.94E–03 |
| 7017 | Microtubule-based process | 141/23 | 1.61E–06 | 2.67E–03 | 0.01 |
| Day 3 | |||||
| 48519 | Negative regulation of biological process | 882/59 | 5.11E–07 | 2.13E–03 | 4.23E–03 |
| 48523 | Negative regulation of cellular process | 839/57 | 5.14E–07 | 2.13E–03 | 4.26E–03 |
| 10941 | Regulation of cell death | 341/30 | 3.31E–06 | 9.13E–03 | 0.03 |
| 42325 | Regulation of phosphorylation | 263/25 | 6.12E–06 | 0.01 | 0.05 |
| 8285 | Negative regulation of cell proliferation | 63/11 | 1.16E–05 | 0.02 | 0.1 |
| Day 7 | |||||
| 6412 | Translation | 131/55 | 0 | 0 | 0 |
| 43043 | Peptide biosynthetic process | 134/55 | 4.44E–16 | 1.84E–12 | 3.67E–12 |
| 6518 | Peptide metabolic process | 184/64 | 5.31E–14 | 1.46E–10 | 4.39E–10 |
| 43604 | Amide biosynthetic process | 151/56 | 9.90E–14 | 2.05E–10 | 8.19E–10 |
| 43603 | Cellular amide metabolic process | 220/68 | 5.20E–12 | 8.60E–09 | 4.30E–08 |
| Day 14 | |||||
| 51726 | Regulation of cell cycle | 162/23 | 8.63E–05 | 0.65 | 0.71 |
| 50678 | Regulation of epithelial cell proliferation | 35/9 | 1.60E–04 | 0.65 | 1 |
| 43604 | Amide biosynthetic process | 151/21 | 2.35E–04 | 0.65 | 1 |
| 42127 | Regulation of cell proliferation | 235/28 | 3.37E–04 | 0.7 | 1 |
| 48660 | Regulation of smooth muscle cell proliferation | 4/8 | 7.38E–04 | 0.74 | 1 |
GO, gene ontology.
All the time points (day) are compared against day 0 (baseline control); Ratio = the number of all genes assigned to this GO term to the number of significantly regulated genes in the data set that can be assigned to this GO term.
GO terms in molecular functions significantly impacted temporally by butyrate infusion.
| GO term | Description | Ratio | FDR | Bonferroni | |
|---|---|---|---|---|---|
| Day 1 | |||||
| 978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 36/5 | 3.28E–07 | 5.23E–04 | 8.36E–04 |
| 987 | Core promoter proximal region sequence-specific DNA binding | 42/5 | 7.28E–07 | 5.23E–04 | 1.85E–03 |
| 1159 | Core promoter proximal region DNA binding | 42/5 | 7.28E–07 | 5.23E–04 | 1.85E–03 |
| 982 | RNA polymerase II core promoter proximal region sequence-specific DNA-binding transcription factor activity | 43/5 | 8.21E–07 | 5.23E–04 | 2.09E–03 |
| 5154 | Epidermal growth factor receptor binding | 2 1/3 | 2.45E–06 | 1.25E–03 | 6.23E–03 |
| Day 3 | |||||
| 978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 36/5 | 4.42E–08 | 6.30E–05 | 1.13E–04 |
| 982 | RNA polymerase II core promoter proximal region sequence-specific DNA-binding transcription factor activity | 42/5 | 9.87E–08 | 6.30E–05 | 2.52E–04 |
| 987 | Core promoter proximal region sequence-specific DNA binding | 42/5 | 9.87E–08 | 6.30E–05 | 2.52E–04 |
| 1159 | Core promoter proximal region DNA binding | 42/5 | 9.87E–08 | 6.30E–05 | 2.52E–04 |
| 977 | RNA polymerase II regulatory region sequence-specific DNA binding | 98/5 | 7.15E–06 | 3.04E–03 | 0.02 |
| Day 7 | |||||
| 3735 | Structural constituent of ribosome | 127/57 | 6.66E–16 | 1.69E–12 | 1.69E–12 |
| 5198 | Structural molecule activity | 180/67 | 1.67E–15 | 2.12E–12 | 4.23E–12 |
| 3723 | RNA binding | 950/184 | 6.20E–08 | 5.26E–05 | 1.58E–04 |
| 44822 | No description available | 840/163 | 4.14E–07 | 2.63E–04 | 1.05E–03 |
| 16491 | Oxidoreductase activity | 270/62 | 1.80E–05 | 9.17E–03 | 0.05 |
| Day 14 | |||||
| 978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 35/6 | 6.26E–10 | 1.45E–06 | 1.59E–06 |
| 987 | Core promoter proximal region sequence-specific DNA binding | 41/6 | 1.72E–09 | 1.45E–06 | 4.36E–06 |
| 1159 | Core promoter proximal region DNA binding | 41/6 | 1.72E–09 | 1.45E–06 | 4.36E–06 |
| 982 | RNA polymerase II core promoter proximal region sequence-specific DNA-binding transcription factor activity | 42/5 | 1.42E–07 | 9.02E–05 | 3.61E–04 |
| 977 | RNA polymerase II regulatory region sequence-specific DNA binding | 99/6 | 3.85E–07 | 1.63E–04 | 9.79E–04 |
GO, gene ontology.
All the time points (day) are compared against day 0 (baseline control); 2. Ratio = the number of all genes assigned to this GO term to the number of significantly regulated genes that can be assigned to this GO term.
Figure 3.Comparison of top 10 functions impacted by butyrate infusion with bar chart (A) and line chart (B). In line chart, 4 dots represent sampling time points of day 1, day 3, day 7, and day 14 (from left to right).
Top 5 upstream regulators in response to butyrate infusion in rumen epithelium.
| D1 | D3 | D7 | D14 | ||||
|---|---|---|---|---|---|---|---|
| Upstream regulator | P value of overlap | Upstream regulator | P value of overlap | Upstream regulator | P value of overlap | Upstream regulator | P value of overlap |
| TP53 | 1.09E–30 | TP53 | 1.16E–34 | RICTOR | 9.54E–50 | PDGF-BB | 1.59E–23 |
| PDGF-BB | 2.75E–26 | PDGF-BB | 1.25E–29 | TP53 | 2.86E–20 | TNF | 1.42E–17 |
| MYC | 2.23E–19 | TNF | 1.70E–26 | NFE2L2 | 1.62E–16 | KRAS | 7.14E–16 |
| TGFB1 | 5.02E–18 | TGFB1 | 5.99E–18 | TCR | 3.23E–16 | TP53 | 1.47E–14 |
| ERBB2 | 7.81E–17 | INSR | 1.07E–17 | MYC | 2.51E–15 | TCR | 6.16E–14 |
Figure 4.Upstream regulator effects illustrated by the downregulated TNF, PDGF-BB, and IL1b.
Figure 5.Heat map: effects of butyrate on the canonical pathways of EIL2 and PPAR, and genes in the pathway’s network.
Figure 6.The most impacted functional regulation networks at different sampling time points.